HeritX

HeritX is a mission-driven research and development organization dedicated to the prevention of inherited cancers, with a primary focus on BRCA1 and BRCA2 mutation carriers. Operating as a virtual biotech, the company accelerates the development of therapies designed to eliminate cancer risk before it starts, aiming to provide medical alternatives to prophylactic surgeries. HeritX collaborates with leading academic institutions and global experts to advance a pipeline of preventive vaccines and targeted interception therapies. Their unique model focuses on pre-cancer biology to identify molecular triggers and stop the disease at its earliest stages. The organization functions as a strategic bridge between academic discovery and clinical application to deliver life-saving preventive medicine.